Viatris Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: MR-146 · MR-146 · Stage I and Stage II Neurotrophic Keratopathy Primary endpoint(s) modified
- Minor: Dymista in Chinese Adolescents Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-06 | NCT07923045 A Phase 1/2 Clinical Trial to Evaluate the Safety and Efficacy of MR-146 in Subjects With… | Phase 1/2 | Recruiting |
Active trials by phase
| Phase 1/2 | 1 | |
| Phase 4 | 1 |
Get alerts when Viatris Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.